Skip to main content
. 2020 Sep 2;10:1214. doi: 10.3389/fonc.2020.01214

Figure 3.

Figure 3

Individual overall survival outcomes of CLDN18-ARHGAP26/6 fusion gastric cancer patients in the Shu et al. and TCGA cohorts. (A) Overall survival outcomes in the Shu et al. cohort; (B) overall survival outcomes in the TCGA cohort; (C) overall survival outcomes in the two cohorts.